A panelist discusses how the FINEARTS-HF trial employed rigorous potassium-monitoring protocols and predefined hyperkalemia thresholds to evaluate finerenone's safety profile in patients with heart ...

Hyperkalemia is a common occurrence in patients with congestive heart failure, particularly when renal failure coexists. The level of renal function in congestive heart failure is often difficult to ...

MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent ...

A new study used plasma potassium measurements to examine the incidence of hyperkalemia and hypokalemia in patients with heart failure. Hyperkalemia and hypokalemia occurred in 24.4% and 20.3% of ...

Hyperkalemia is a potentially serious condition that can result in life-threatening cardiac arrhythmias and is associated with an increased mortality risk. Patients older than 65 years who have an ...

India: An artificial intelligence (AI)-based electrocardiogram (ECG) interpretation system demonstrated high accuracy in ...

Please provide your email address to receive an email when new articles are posted on . Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease (CKD), ...

Please provide your email address to receive an email when new articles are posted on . Hyperkalemia is a relatively common transient acute electrolyte abnormality. Due to its propensity to cause ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

Acute hyperkalemia is when significant changes to potassium levels occur over a short time, and it is more serious than having chronic hyperkalemia, or regularly high potassium levels. However, both ...

Finerenone use in trial patients with HFpEF or HFmrEF increased hyperkalemia risk, especially in those with CKD. Finerenone use in patients with heart failure and preserved or mildly reduced ejection ...